We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Glial Precursor Cells May Play a Role in ALS

By LabMedica International staff writers
Posted on 20 Dec 2010
A new study has identified a group of immature cells that persist in the adult brain and spinal cord that undergo dramatic changes in amyotrophic lateral sclerosis (ALS), and could lead to new insights on the disease.

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) examined an omnipresent population of glial progenitors known as NG2+, a line of cells that have the ability to develop into oligodendrocytes, and in addition which undergo dramatic changes in response to injury and demyelination. More...
The researchers tracked the fate of the NG2+ cells in both normal mice and mice with a mutant form of the gene that causes ALS, and found that NG2+ cells in the postnatal central nervous system (CNS) generate myelinating oligodendrocytes, but not astrocytes or neurons.

According to the researchers, these results indicate that NG2+ cells in the normal CNS are oligodendrocyte precursors with restricted lineage potential, and that cell loss and gliosis are not sufficient to alter the lineage potential of these progenitors. However, in regions of neuro-degeneration in the spinal cord of the ALS mice, the NG2+ cells exhibited enhanced proliferation and accelerated differentiation into oligodendrocytes, although remaining committed to the oligodendrocyte lineage. The study was published early online on November 17, 2010, in Neuron.

"In the model ALS mice we studied, it's as though NG2+ cells step onto a high-speed treadmill,” said lead author Dwight Bergles, PhD, an associate professor in the JHU department of neuroscience. "They undergo explosive division, morph more readily into abnormal-looking oligodendrocytes and then, uncharacteristically, those differentiated cells quickly die. The brakes that normally hold these cells in check appear to be gone in ALS.”

"This goes much further than simply confirming a negative finding about these mysterious cells,” added coauthor Shin Kang, PhD. "We've answered a question, but the new observation about the overgrowth could lead to an entirely new understanding of ALS.”

Oligodendrocytes are cells that help speed the transmission of electrical impulses by providing the myelin sheath insulation surrounding nerve cells. Their main function is the insulation of axons in the CNS of higher vertebrates. A single oligodendrocyte can extend its processes to 50 axons, wrapping around approximately 1 mm of myelin sheath around each axon.

Related Links:

Johns Hopkins University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.